论文部分内容阅读
目的对比分析国产缬沙坦和合资缬沙坦治疗高血压的成本-效果。方法从我院随机抽取86例于2014年3月至2015年3月门诊接诊的高血压患者作为研究对象,并随机分成两组,对照组43例采用国产缬沙坦治疗,观察组43例采用合资缬沙坦治疗,对比两组患者的成本-效果。结果对照组的总有效率为88.37%,不良反应的发生率为13.95%,和观察组的93.02%和9.3%进行组间比较,差异不明显(P>0.05)。同时,对照组的成本-效果比为4.1947,观察组为7.0044,对照组低于观察组。结论采用国产缬沙坦和合资缬沙坦治疗高血压的临床效果相差不大,但是使用国产缬沙坦治疗的经济成本更低,所以更适宜临床推广应用。
Objective To compare and analyze the cost-effectiveness of domestic valsartan and valsartan in the treatment of hypertension. Methods A total of 86 hypertensive patients admitted from March 2014 to March 2015 in our hospital were randomly divided into two groups. 43 cases in the control group were treated with valsartan, and 43 cases in the observation group The use of joint vental valsartan treatment, the cost-benefit comparison of two groups of patients. Results The total effective rate was 88.37% in the control group, the incidence of adverse reactions was 13.95%, and 93.02% and 9.3% in the observation group were not significantly different (P> 0.05). Meanwhile, the cost-effectiveness ratio of the control group was 4.1947, the observation group was 7.0044, while the control group was lower than the observation group. Conclusion The clinical efficacy of domestic valsartan and valsartan in the treatment of hypertension is similar, but the cost of domestic valsartan treatment is lower, so it is more suitable for clinical application.